Myelodysplastic Myeloproliferative Neoplasm Not Otherwise Specified

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2026-03-13
Clinical Trial Update: Ropeginterferon Alfa-2b for the Treatment of Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromes and Chronic Myelomonocytic Leukemia [Phase 2]
This clinical trial update describes a Phase 2 study of Ropeginterferon alfa-2b for treating myelodysplastic/myeloproliferative neoplasm ove…
CLINICAL_TRIALS research · 2026-02-23
Clinical Trial Update: Onvansertib for the Treatment of Recurrent or Refractory Chronic Myelomonocytic Leukemia and Myelodysplastic Syndrome/MPN Overlap Neoplasms [Phase 1]
This clinical trial update notes a Phase 1 study of Onvansertib for recurrent or refractory chronic myelomonocytic leukemia and myelodysplas…
CLINICAL_TRIALS trial_result · 2024-09-19
Clinical Trial Update: Luspatercept With or Without Hydroxyurea for the Treatment of Myelodysplastic/Myeloproliferative Neoplasms With Ring Sideroblasts and Thrombocytosis or Unclassifiable With Ring Sideroblasts [Phase 2]
Phase 2 trial evaluating luspatercept with or without hydroxyurea for myelodysplastic/myeloproliferative neoplasms with ring sideroblasts an…